Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 MicroRNAs in the thyroid.

Literature DB >> 27923454

MicroRNAs in the thyroid.

Myriem Boufraqech¹, Joanna Klubo-Gwiezdzinska², Electron Kebebew³.

Abstract

MicroRNAs (miRNAs) are small non-coding RNA comprising approximately 19-25 nucleotides. miRNAs can act as tumour suppressors or oncogenes, and aberrant expression of miRNAs has been reported in several human cancers and has been associated with cancer initiation and progression. Recent evidence suggests that miRNAs play a major role in thyroid carcinogenesis. In this review, we summarize the role of miRNAs in thyroid cancer and describe the oncogenic or tumour suppressor function of miRNAs as well as their clinical utility as prognostic or diagnostic markers in thyroid cancer. Published by Elsevier Ltd.

Entities: Chemical Disease Gene Mutation Species

Keywords: circulating microRNA; diagnosis; microRNA; prognosis; thyroid cancer; treatment

Mesh：

Substances：

Year: 2016 PMID： 27923454 PMCID： PMC5147609 DOI： 10.1016/j.beem.2016.10.001

Source DB: PubMed Journal: Best Pract Res Clin Endocrinol Metab ISSN： 1521-690X Impact factor: 4.690

146 in total

1. High iodine blocks a Notch/miR-19 loop activated by the BRAF(V600E) oncoprotein and restores the response to TGFβ in thyroid follicular cells.

Authors: Cesar Seigi Fuziwara; Edna Teruko Kimura
Journal: Thyroid Date: 2014-01-29 Impact factor: 6.568

2. The role of microRNA genes in papillary thyroid carcinoma.

Authors: Huiling He; Krystian Jazdzewski; Wei Li; Sandya Liyanarachchi; Rebecca Nagy; Stefano Volinia; George A Calin; Chang-Gong Liu; Kaarle Franssila; Saul Suster; Richard T Kloos; Carlo M Croce; Albert de la Chapelle
Journal: Proc Natl Acad Sci U S A Date: 2005-12-19 Impact factor: 11.205

Review 3. Molecular analysis of thyroid tumors.

Authors: Yuri E Nikiforov
Journal: Mod Pathol Date: 2011-04 Impact factor: 7.842

4. MicroRNA profiling of sporadic and hereditary medullary thyroid cancer identifies predictors of nodal metastasis, prognosis, and potential therapeutic targets.

Authors: Deepak Abraham; Nicole Jackson; Justin S Gundara; JingTing Zhao; Anthony J Gill; Leigh Delbridge; Bruce G Robinson; Stan B Sidhu
Journal: Clin Cancer Res Date: 2011-05-27 Impact factor: 12.531

5. Prognostic factors for thyroid carcinoma. A population-based study of 15,698 cases from the Surveillance, Epidemiology and End Results (SEER) program 1973-1991.

Authors: F D Gilliland; W C Hunt; D M Morris; C R Key
Journal: Cancer Date: 1997-02-01 Impact factor: 6.860

6. Antisense-miR-21 enhances differentiation/apoptosis and reduces cancer stemness state on anaplastic thyroid cancer.

Authors: Vahid Haghpanah; Parviz Fallah; Rezvan Tavakoli; Mahmood Naderi; Hilda Samimi; Masoud Soleimani; Bagher Larijani
Journal: Tumour Biol Date: 2015-08-20

7. Prognostic implications of miR-146b expression and its functional role in papillary thyroid carcinoma.

Authors: Chen-Kai Chou; Kuender D Yang; Fong-Fu Chou; Chao-Cheng Huang; Yueh-Wen Lan; Ya-Fang Lee; Hong-Yo Kang; Rue-Tsuan Liu
Journal: J Clin Endocrinol Metab Date: 2012-12-21 Impact factor: 5.958

8. Suppression of non-small cell lung tumor development by the let-7 microRNA family.

Authors: Madhu S Kumar; Stefan J Erkeland; Ryan E Pester; Cindy Y Chen; Margaret S Ebert; Phillip A Sharp; Tyler Jacks
Journal: Proc Natl Acad Sci U S A Date: 2008-02-28 Impact factor: 11.205

9. MicroRNA-222 and microRNA-146b are tissue and circulating biomarkers of recurrent papillary thyroid cancer.

Authors: James C Lee; Jing Ting Zhao; Roderick J Clifton-Bligh; Anthony Gill; Justin S Gundara; Julian C Ip; Anthony Glover; Mark S Sywak; Leigh W Delbridge; Bruce G Robinson; Stanley B Sidhu
Journal: Cancer Date: 2013-10-28 Impact factor: 6.860

10. MicroRNA-613 inhibits cell growth, migration and invasion of papillary thyroid carcinoma by regulating SphK2.

Authors: Wangwang Qiu; Zhili Yang; Youben Fan; Qi Zheng
Journal: Oncotarget Date: 2016-06-28

23 in total

1. miR-650 promotes motility of anaplastic thyroid cancer cells by targeting PPP2CA.

Authors: Francesca Maria Orlandella; Raffaela Mariarosaria Mariniello; Paola Lucia Chiara Iervolino; Esther Imperlini; Annalisa Mandola; Anna Verde; Anna Elisa De Stefano; Katia Pane; Monica Franzese; Silvia Esposito; Fulvio Basolo; Stefania Orrù; Giuliana Salvatore
Journal: Endocrine Date: 2019-03-29 Impact factor: 3.633

Review 2. Altered Epigenetic Mechanisms in Thyroid Cancer Subtypes.

Authors: Maryam Zarkesh; Azita Zadeh-Vakili; Fereidoun Azizi; Forough Foroughi; Maziar Mohammad Akhavan; Mehdi Hedayati
Journal: Mol Diagn Ther Date: 2018-02 Impact factor: 4.074

3. LncRNA MCM3AP-AS1 promotes proliferation and invasion through regulating miR-211-5p/SPARC axis in papillary thyroid cancer.

Authors: Meihua Liang; Jinliang Jia; Lili Chen; Biyue Wei; Qiang Guan; Zhaoming Ding; Jiawei Yu; Rui Pang; Guoqing He
Journal: Endocrine Date: 2019-04-27 Impact factor: 3.633

4. Inflammatory Components of the Thyroid Cancer Microenvironment: An Avenue for Identification of Novel Biomarkers.

Authors: Tara Jarboe; Neha Y Tuli; Sanjukta Chakraborty; Rachana R Maniyar; Nicole DeSouza; Augustine Moscatello; Jan Geliebter; Raj K Tiwari
Journal: Adv Exp Med Biol Date: 2021 Impact factor: 2.622

5. Down-regulation and clinical significance of miR-7-2-3p in papillary thyroid carcinoma with multiple detecting methods.

Authors: Hua-Yu Wu; Yi Wei; Shang-Ling Pan
Journal: IET Syst Biol Date: 2019-10 Impact factor: 1.615

Review 6. Molecular mechanisms of radioactive iodine refractoriness in differentiated thyroid cancer: Impaired sodium iodide symporter (NIS) expression owing to altered signaling pathway activity and intracellular localization of NIS.

Authors: Ji Min Oh; Byeong-Cheol Ahn
Journal: Theranostics Date: 2021-04-15 Impact factor: 11.556